MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Sintx Technologies Operating Cycle 2011-2026 | SINT
Annual Operating Cycle Sintx Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 526 | 969 | 484 | 1.24 K | 1.06 K | 5.51 K | 112 | 736 | 583 | 579 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.51 K | 112 | 1.18 K |
Quarterly Operating Cycle Sintx Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 366 | 435 | 207 | - | 366 | 496 | 500 | - | - | 739 | 594 | - | 835 | 1.04 K | 770 | - | 387 | 836 | 798 | - | 895 | 291 | 348 | - | 462 | 498 | 904 | - | - | 121 | 143 | - | 192 | 336 | 712 | - | 904 | 684 | 882 | - | 558 | 662 | 673 | - | 588 | 704 | 644 | - | 578 | 735 | 261 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.04 K | 121 | 571 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
274 | $ 33.23 | 1.9 % | $ 1.47 B |  USA |
 |
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
76.7 | $ 7.08 | 2.98 % | $ 508 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
299 | $ 3.75 | -1.83 % | $ 130 M | USA |
 |
Alphatec Holdings
ATEC
|
351 | $ 13.37 | 2.06 % | $ 1.91 B | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.7 | -1.44 % | $ 175 M |  France |
 |
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | USA |
 |
Electromed
ELMD
|
228 | $ 24.35 | 4.46 % | $ 206 M | USA |
 |
Bio-Rad Laboratories
BIO
|
304 | $ 253.63 | -13.27 % | $ 7.16 B | USA |
 |
Conformis
CFMS
|
216 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
274 | $ 36.37 | -3.05 % | $ 5.42 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
278 | $ 41.78 | 0.26 % | $ 1.29 B | USA |
 |
Boston Scientific Corporation
BSX
|
184 | $ 74.89 | 1.04 % | $ 110 B | USA |
 |
Abbott Laboratories
ABT
|
183 | $ 112.43 | 0.86 % | $ 196 B | USA |
 |
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | USA |
 |
Delcath Systems
DCTH
|
357 | $ 9.26 | 1.48 % | $ 264 M | USA |
 |
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
266 | $ 13.4 | 2.76 % | $ 362 M | USA |
 |
Inogen
INGN
|
86.1 | $ 5.8 | 0.17 % | $ 137 M | USA |
 |
InMode Ltd.
INMD
|
246 | $ 14.41 | 0.79 % | $ 1.14 B | Israel |
 |
IRadimed Corporation
IRMD
|
308 | $ 100.64 | 0.8 % | $ 1.28 B | USA |
 |
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
337 | $ 1.49 | 4.58 % | $ 58.3 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
156 | - | - | $ 10.2 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Integer Holdings Corporation
ITGR
|
120 | $ 85.98 | 0.73 % | $ 2.89 B | USA |
 |
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | USA |
 |
Penumbra
PEN
|
386 | $ 340.06 | 0.4 % | $ 13.1 B | USA |
 |
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
251 | $ 18.55 | 0.03 % | $ 122 M | USA |
 |
Insulet Corporation
PODD
|
281 | $ 244.13 | 1.37 % | $ 17.1 B | USA |
 |
Globus Medical
GMED
|
343 | $ 88.42 | 1.38 % | $ 12 B | USA |